Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest fool.com · about 6 hours ago

Why EPAM Systems Stock Rocketed Higher This Week

Citigroup reduced its price target on EPAM Systems stock. EPAM Systems announced a new partnership with OpenAI.

Stocks

More recent coverage

Page 2
GRAL newsfilecorp.com · about 6 hours ago

GRAL DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages GRAIL, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 4 Deadline in Securities Class Action - GRAL

New York, New York--(Newsfile Corp. - August 1, 2026) - WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the "Class Period"), of the important August 4, 2026 lead plaintiff deadline. SO WHAT: If you purchased GRAIL common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

PHH globenewswire.com · about 6 hours ago

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH

NEW YORK, Aug. 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2026.

GNS newsfilecorp.com · about 7 hours ago

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Genius Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Against Citadel Securities LLC and Virtu Americas LLC - GNS

New York, New York--(Newsfile Corp. - August 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased or sold Genius securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

KD businesswire.com · about 7 hours ago

Kyndryl Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Kyndryl Holdings, Inc. - KD

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD). On February 9, 2026, the Company disclosed that it would be unable to timely file its Form 10-Q Report for the quarter ended December 31, 2025 and that “the Company anticipates reporting material weaknesses i.

CCOI newsfilecorp.com · about 7 hours ago

Kaplan Fox Notifies Cogent Communications Holdings, Inc. (CCOI) Investors of a Securities Class Action Deadline on September 21, 2026

New York, New York--(Newsfile Corp. - August 1, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Cogent Communications Holdings, Inc. ("Cogent" or the "Company") (NASDAQ: CCOI) on behalf of investors that purchased or otherwise acquired Cogent securities between February 29, 2024 and May 1, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Cogent and have suffered losses, you may CLICK HERE to contact us.

AMAT seekingalpha.com · about 7 hours ago

Applied Materials: July Purged Positioning, Not The Thesis

Applied Materials (AMAT) delivered record Q2 FY2026 revenue of $7.91B (+11% Y/Y) and non-GAAP EPS of $2.86 (+20% Y/Y). Management raised CY2026 equipment growth guidance to 30%+, with improved order visibility and strong DRAM and AGS segment performance. Despite a ~40% drawdown from highs, fundamentals remain robust, and the recent correction is attributed to sector positioning rather than company weakness.

MDCX proactiveinvestors.com · about 7 hours ago

Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI

Medicus Pharma (NASDAQ:MDCX) earlier this week announced that the US Food and Drug Administration (FDA) has cleared the company's Phase 2b registration-enabling clinical trial for SkinJect in patients with Gorlin syndrome, representing an important regulatory milestone for its lead investigational asset. Speaking with Proactive, CEO Raza Bokhari said the FDA had approved the company's proposed study following discussions and feedback, allowing Medicus Pharma (NASDAQ:MDCX) to move ahead with a crossover registration study involving up to 50 patients.

FUTU newsfilecorp.com · about 7 hours ago

FUTU DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Futu Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FUTU

New York, New York--(Newsfile Corp. - August 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Futu Holdings Limited (NASDAQ: FUTU) between May 24, 2023 and May 27, 2026, inclusive (the "Class Period"), of the important August 25, 2026 lead plaintiff deadline. SO WHAT: If you purchased Futu securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

SKW businesswire.com · about 7 hours ago

Skyworks Solutions Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Skyworks Solutions, Inc. - SKW

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Skyworks Solutions, Inc. (NasdaqGS: SKW) (“Skyworks” or the “Company”). On February 5, 2025, the Company announced its financial results for the first quarter of fiscal year 2025, disclosing lower-than anticipated revenue guidance for the second quarter of fiscal year 202.

COLL seekingalpha.com · about 7 hours ago

Collegium Pharmaceutical: Pain Cash Flows Are Funding An ADHD Re-Rating

Collegium Pharmaceutical (COLL) is transitioning from a pain-management roll-up to a CNS platform, leveraging stable pain cash flows to fuel ADHD franchise growth. The AZSTARYS acquisition, funded with $350M cash and $300M debt, is expected to deliver $60–70M revenue in 2026 and $50M+ annual synergies within 12 months. COLL's 2026 guidance is $865–895M in revenue and $475–500M adjusted EBITDA, with a 55% margin, reflecting only partial-year AZSTARYS contribution and early synergies.

BE fool.com · about 7 hours ago

Is Bloom Energy in Its Nvidia Moment?

Bloom Energy reported stellar results for the second quarter of 2026, surpassing $1 billion in quarterly revenue for the first time. The energy technology company also reported a profit of $196.2 million.

← Newer
Older →